These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10532018)

  • 21. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States.
    Coffin SE; Elser J; Marchant C; Sawyer M; Pollara B; Fayorsey R; Nelson L; Lawley D; Goveia M; Stek J; Hille D; DiNubile MJ
    Pediatr Infect Dis J; 2006 Jul; 25(7):584-9. PubMed ID: 16804426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of rotavirus: Implications for child health.
    Bishop R
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S81-5. PubMed ID: 19799704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nosocomial rotavirus infections].
    Korycka M
    Przegl Epidemiol; 2004; 58(3):467-73. PubMed ID: 15730011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawal of rotavirus vaccine recommendation.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Nov; 48(43):1007. PubMed ID: 10577495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
    Steele AD; Cunliffe N; Tumbo J; Madhi SA; De Vos B; Bouckenooghe A
    J Infect Dis; 2009 Nov; 200 Suppl 1():S57-62. PubMed ID: 19817615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E; Galvani AP
    Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus infections.
    Katyal R; Rana SV; Singh K
    Acta Virol; 2000 Oct; 44(5):283-8. PubMed ID: 11252673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [500,000 cases per year in Germany. There is now a vaccine for control of rotavirus infection].
    MMW Fortschr Med; 2006 Oct; 148(41):6-7. PubMed ID: 17190246
    [No Abstract]   [Full Text] [Related]  

  • 32. Rotavirus disease and its prevention.
    Widdowson MA; Bresee JS; Gentsch JR; Glass RI
    Curr Opin Gastroenterol; 2005 Jan; 21(1):26-31. PubMed ID: 15687881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short report on highlights of world-wide development of RIX4414: a Latin American experience.
    Linhares AC; Ruiz-Palacios GM; Guerrero ML; Salinas B; Perez-Schael I; Clemens SA; Innis B; Yarzabal JP; Vespa G; Cervantes Y; Hardt K; De Vos B
    Vaccine; 2006 May; 24(18):3784-5. PubMed ID: 16098636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
    J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.
    Coffin SE; Offit PA
    Adv Pediatr Infect Dis; 1997; 13():333-48. PubMed ID: 9544318
    [No Abstract]   [Full Text] [Related]  

  • 37. Rotavirus surveillance--worldwide, 2001-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1255-7. PubMed ID: 19023263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of rotavirus vaccines in developing countries].
    Delacour H
    Med Trop (Mars); 2009 Aug; 69(4):327-32. PubMed ID: 19725379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation.
    Wright PF; Tajima T; Thompson J; Kokubun K; Kapikian A; Karzon DT
    Pediatrics; 1987 Oct; 80(4):473-80. PubMed ID: 2821477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and implementation policy for use of oral, live, reassortant rotavirus vaccine in the neonatal intensive care unit.
    Shah SI
    Adv Neonatal Care; 2008 Jun; 8(3):148-9. PubMed ID: 18535419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.